JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09B |
| 2 |
Broadcom
AVGO
|
+$1.03B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$970M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$877M |
| 5 |
Verizon
VZ
|
+$875M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.37B |
| 3 |
TWX
Time Warner Inc
TWX
|
+$764M |
| 4 |
IBM
IBM
|
+$737M |
| 5 |
Philip Morris
PM
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Financials | 14% |
| 3 | Technology | 12.71% |
| 4 | Healthcare | 9.7% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4026
McGrath RentCorp
MGRC
$2.81B
| $470K | ﹤0.01% |
7,434
-33,649
| -82% | -$2.07M |
2016 Q4
6 quarters
|
|
4027
Regional Management Corp
RM
$286M
| $470K | ﹤0.01% |
13,405
-48,311
| -78% | -$1.69M |
2016 Q4
6 quarters
|
|
|
MLNT
4028
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $467K | ﹤0.01% |
14,710
+14,054
| +2,142% | +$506K |
2017 Q4
2 quarters
|
|
4029
Calix
CALX
$2.2B
| $466K | ﹤0.01% |
59,778
-2,156
| -3% | -$15.2K |
2017 Q4
2 quarters
|
|
4030
Casella Waste Systems
CWST
$4.97B
| $463K | ﹤0.01% |
18,103
-51,817
| -74% | -$1.28M |
2017 Q4
2 quarters
|
|
|
EIGR
4031
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $462K | ﹤0.01% |
+1,263
| New | +$450K |
2018 Q2
0 quarters
|
|
4032
Protagonist Therapeutics
PTGX
$9.01B
| $461K | ﹤0.01% |
68,591
+66,296
| +2,889% | +$509K |
2017 Q4
2 quarters
|
|
|
DBVT
4033
DBV Technologies S.A. American Depositary Shares
DBVT
$705M
| $460K | ﹤0.01% |
2,386
+2,218
| +1,320% | +$500K |
2015 Q1
13 quarters
|
|
4034
Invesco Dorsey Wright Emerging Markets Momentum ETF
PIE
$255M
| $460K | ﹤0.01% |
22,978
-409
| -2% | -$8.63K |
2013 Q2
20 quarters
|
|
|
SRNE
4035
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $460K | ﹤0.01% |
+63,863
| New | +$434K |
2018 Q2
0 quarters
|
|
|
HIVE
4036
DELISTED
Aerohive Networks
HIVE
| $460K | ﹤0.01% |
115,920
-42,387
| -27% | -$174K |
2017 Q4
2 quarters
|
|
4037
ATN International
ATNI
$432M
| $459K | ﹤0.01% |
8,696
-10,947
| -56% | -$615K |
2016 Q2
8 quarters
|
|
4038
Genesco
GCO
$377M
| $457K | ﹤0.01% |
11,495
-4,916
| -30% | -$209K |
2013 Q2
20 quarters
|
|
4039
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$405M
| $456K | ﹤0.01% |
24,917
-301
| -1% | -$5.49K |
2013 Q2
20 quarters
|
|
4040
National Grid
NGG
$75.7B
| $456K | ﹤0.01% |
9,230
-26,167
| -74% | -$1.32M |
2013 Q2
20 quarters
|
|
4041
Reading International Class A
RDI
$43.7M
| $453K | ﹤0.01% |
28,405
+631
| +2% | +$10K |
2016 Q4
6 quarters
|
|
|
EARN
4042
Ellington Residential Mortgage REIT
EARN
$150M
| $452K | ﹤0.01% |
41,485
-250,572
| -86% | -$2.82M |
2016 Q1
9 quarters
|
|
4043
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$420M
| $452K | ﹤0.01% |
4,540
+16
| +0.4% | +$1.68K |
2017 Q3
3 quarters
|
|
4044
Mercury Systems
MRCY
$5.12B
| $449K | ﹤0.01% |
11,813
-27,527
| -70% | -$1.07M |
2016 Q2
8 quarters
|
|
4045
Companhia Siderúrgica Nacional
SID
$1.49B
| $449K | ﹤0.01% |
+222,061
| New | +$526K |
2018 Q2
0 quarters
|
|
|
LN
4046
DELISTED
LINE Corporation
LN
| $449K | ﹤0.01% |
10,950
-15,053
| -58% | -$568K |
2017 Q2
4 quarters
|
|
|
OMP
4047
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
| $446K | ﹤0.01% |
24,455
-1,915
| -7% | -$34.8K |
2017 Q3
3 quarters
|
|
4048
Atlanta Braves Holdings Series B
BATRK
$3.35B
| $444K | ﹤0.01% |
17,200
-14,116
| -45% | -$341K |
2016 Q2
8 quarters
|
|
|
XENT
4049
DELISTED
Intersect ENT, Inc
XENT
| $444K | ﹤0.01% |
11,868
+5,250
| +79% | +$206K |
2014 Q3
15 quarters
|
|
4050
Gladstone Investment Corp
GAIN
$627M
| $440K | ﹤0.01% |
37,357
-51,830
| -58% | -$583K |
2015 Q4
10 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2018 Portfolio in Review
As of Q2 2018, JP Morgan Chase held 5,918 positions worth $486B, up 4.2% from $467B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2018 filing shows 539 new, 2,430 increased, 2,080 reduced and 346 closed positions. Its largest new stake was Evergy: 3,598,208 shares worth $202M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2018 buy was Evergy: 3,598,208 shares worth $202M.
- JP Morgan Chase added most to Salesforce in Q2 2018, an estimated $1.09B increase.
- JP Morgan Chase's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.58B.
- JP Morgan Chase fully exited Time Warner Inc in Q2 2018, selling an estimated $764M.
- JP Morgan Chase's ten largest holdings make up 17% of its $486B portfolio in Q2 2018.
- JP Morgan Chase opened 539 new positions and closed 346 in Q2 2018.
- JP Morgan Chase's portfolio value rose 4.2% quarter-over-quarter to $486B.
Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.